Try our Advanced Search for more refined results
Health - May, 2008
172 articles
- Merck, Fosamax Plaintiffs Clash Over Discovery
- FDA Wants To Reclassify Digital Mammograms
- Vioxx Deal Holds Up Even After Appeals Wins: Experts
- Oxford Gene Sues BioArray Over BeadChip Patent
- WellPoint Hit With ERISA Suit Over March Stock Drop
- Court Rules Appeal Of Arriva Bankruptcy Plan Moot
- Wyeth Sues Sandoz Over Contraceptive Patent
- Ex-Hospital CEO Charged With Dodging $64M Order
- Draft Guidance On Certification Creates Ambiguity
- First DataBank Pays Over $1M To Settle AWP Case
- Judge Nixes RICO Class Action Against Blue Cross
- California Senate Mulls Sick Leave Bill
- FDA Warns Steris Over Sterilization Device
- Court Certifies Classes in Monsanto Pension Plan Suit
- Connecticut Says McKesson Inflated Drug Prices
- Judge Rules Stanford's HIV Test Patents Obvious
- Diversion Of Ambulance Can Violate EMTALA
- Drugmakers File 2nd Suit To Thwart Generic Xyzal
- Two Courts Overturn Vioxx Rulings Against Merck
- FDA Seeks To Amend Drugs' Pregnancy Labeling
- Medtronic Wins $250M From Boston Scientific
- Australian Court Upholds Pfizer's Lipitor Patent
- AstraZeneca Sues Barr Over Crohn's Disease Drug
- Two More From Perkins Coie Join King & Spalding
- FDA Seeks Recall Of 'Illegal' ED Drug
- DLA Piper's Schulman Joins Pfizer As GC
- Wyeth Makes Its Case For Preemption To High Court
- Express Scripts Settles Drug-Switch Case For $9.5M
- Vote Looms Over Right To Sell Prescription Info
- Ex-Connetics VP Settles Insider Trading Charges
- Germany Fines Bayer $16M On Price-Fixing Charges
- Plaintiffs Win Partial Victory In E-Ferol Class Action
- 3rd Circuit Rejects Isolagen Appeal As Premature
- OIG's Changes Improve Self-Disclosure Protocol
- Abbott, Roche Settle Glucose Test Patent Dispute
- MedImmune, Genentech Strike Deal In Synagis Case
- Consulting Firm Exits Medical Monitoring Suit
- FDA, Medicare Launch Drug Safety Initiative
- Judge Keeps Failure-To-Warn Claim In Baxter Suit
- Medtronic's Impact On Medical Device Manufacturers
- GE Sues To Invalidate SonoSite Ultrasound Patent
- 9th Circuit Scraps Antitrust Suit Against Providence
- Zyprexa 3rd-Party Payers' Class Bid Draws Flak
- Aredia MDL Parties Select First 10 Cases For Trial
- Report Links Chantix To Seizures, Heart Trouble
- Medtronic Shells Out $75M In Qui Tam Deal
- Baxter Sues Talecris Over Blood Test Patents
- Pfizer Using Quigley Co. To Dodge Claims: Insurer
- Icahn Forces Biogen's Hand In Document Spat
- Wilson Sonsini Adds Mylan's Ex-Chief Legal Officer
- Fosamax Plaintiffs Try To Force Merck's Hand
- Merck Wins U.K. Appeal For Propecia Patent
- Bausch & Lomb Looks Askance At Patent Stay Ruling
- Brand-Name, Generics Deals Stifle Competition: FTC
- Lawmakers Ask Drug Companies To Improve Ads
- Fresenius Must Hand Over Epogen Docs: 8th Circuit
- Wyeth Calls For End To Discovery In Prempro MDL
- Merck Settles With States Over Vioxx Marketing
- Mirapex Plaintiffs Add Punitive Damages To Claim
- Pfizer Still Safe From Quigley Suit, Judge Rules
- McKesson Plotted To Fix Drug Prices, City Claims
- Judge Nixes Abbott's Patent Defense In Norvir Case
- Hospitals Have Mandamus Relief: Texas High Court
- Wyeth, Nycomed Take Aim At Sandoz Over Protonix
- 9th Circuit Rejects NLRB's Ruling On Button Ban
- Companies Fined For Water Contamination In Arizona
- 'No Reliance' Defense Defeats Class Certification
- FDA Stresses Dangers Of Transplant Drugs
- Judge Finalizes $2.25M Cardia Settlement
- Mix-Up Leads To Acne Medication Recall
- Judge Blasts Parties For Delay In Guidant MDL
- 5th Circ. Upholds Ruling Against Texas Doctors Group
- Leiner Can Offer Stalking Horse Breakup Fee: Judge
- Appeals Court Denies Full Pay For Emergency Services
- Biovail To Pay $24.6M Over Cardizem Marketing
- Order May Clarify Southern Calif. Patent Local Rules
- FDA Shuts Down Unlicensed Cough Medicine Co.
- McKesson Ruling Still Poses Challenges For IP Lawyers
- Judge Tosses Nearly All Of J&J's Red Cross Claims
- Court Won't Enjoin Nova In Glucose Meter Fight
- Bayer Pulls Remaining Trasylol From U.S. Market
- EU Steps Up Antitrust Probe Of Drug Market
- Nutraceutical Stock Promoter To Pay Over $2M
- 9th Circ. Grants L.A. Biomed New Graft Patent Trial
- Judge Tinkers With Stent Claim Order Again
- FDA's Exclusivity Forfeiture Saga Continues
- Salix Sues Novel Labs Over Bowel Cleanser Patent
- Peer Review Protections After Amendment 7
- Kids' Respiratory Problems Surge After Katrina: CDC
- Federal Circuit Affirms Aventis' Inequitable Conduct
- Fen-Phen Lawyers' Fraud Trial Gets Under Way
- Appeals Court Overturns $7.75M Vioxx Ruling
- FDA Puts Immucor On Notice For Safety Violations
- Court Lets Bone-Cleaning Firm Add Patent To Suit
- Zimmer Fights Class Action Following Kickback Probe
- FTC Furthers Probe Into Mylan's Keppra Settlement
- U.S. Gives Opinion On Qui Tam Pfizer Suit
- Labeling Changes And FDA's Oversight Of Drug Safety
- Fed. Circ. Revives Stryker-Acumed Nail Patent Case
- Atrium Withdraws Some Catheters For Heparin Fears
- Glycoproducts Infringed Mannatech Patent: Jury
- StemCells Fires Back At Neuralstem Over New Patent
- E-Prescribing's Dirty Little Secret
- Supreme Court Declines To Hear Apotex Appeal
- Suit Claims CareCore Strangled Competition
- Medical Dye Makers Face Another Liability Suit
- Zyprexa Lawyers Renew Quest For Additional Fees
- 5 Years On, Trademark Fraud Ruling Still Resonates
- Leiner Settles DOJ Probe Into Drug Plant Violations
- Fed. Circ. Upholds Diazyme Win On Assays Patents
- Justice Recusals Allow Apartheid Claims To Continue
- SEC Accuses Doctors Of Insider Trading
- Invitrogen Strikes Deal For Stem Cell Patents
- Litigators Urge Clarity Over Punitive Damage Rules
- Pain Pumps: The Next Medical Device Litigation Wave?
- Barr Eyes Mid-2008 Launch For Generic Yasmin
- Canadian Court Nixes J&J Suit V. Boston Scientific
- Schering-Plough Sued Over Coppertone Trade Dress
- Policy Proxy Bids Waste Company Time: Experts
- FTC Tries To Stop Virginia Hospital Deal
- Bausch & Lomb Told To Turn Over Disputed Docs
- Medtronic Yanks Heparin-Coated Cardiac Devices
- EC To Simplify Medical Device Legislation
- Ephedra MDL Nears End With Score Of Dismissals
- The FTC's Ongoing Opposition To Reverse Payments
- Judge Certifies Wellbutrin Antitrust Class Action
- Federal Circuit Weighs Limits On Business Methods
- Lilly Fails To Halt Maine Zyprexa Wrongful-Death Suit
- Lawmakers Fight FDA's Anti-Estriol Stance
- Lawmakers Grill Pharma Execs Over Drug Ads
- Bladder Drugs May Hasten Decline Of Aged: Study
- ImClone Cries Fraud Over Erbitux Deal
- Federal Circuit Won't Rehear Celebrex Patent Dispute
- Co-Counsel Joins Outcry Over Fees In Guidant MDL
- Alphatec To Pay $11M In Spinal Screw Patent Deal
- Prescription Drug Preemption Awaits Resolution
- AGs Examining J&J Nominal Pricing Deals
- FDA Panel Rejects New Uses For Cancer Drug
- Teva Sues To Invalidate Nexium Patents
- 6th Circ. Tosses Antitrust Suit Against PPO
- Judge Trashes Requests For Extra Attorneys' Fees
- Neuralstem Seeks To Restart Stayed Patent Suit
- A Big Leap For E-Pedigree Standards, Technologies
- Schneider & Wallace Calls Guidant Fees Unfair
- WIPO Clears Boston Scientific Of Infringement
- Ocean Tomo Offers New Site For Patent Transactions
- PSN Porcelain Veneer Patent Noninfringed: Fed Circ.
- Another Symbicort Patent Revoked In EU
- Jones Day Health Group Co-Chair Lured To Skadden
- Big Pharma To Defend Ad Practices At House Hearing
- FDA Warns Stryker Again Over Quality Control
- Procter & Gamble Targets J&J's Tooth Whitener
- McKesson Ponies Up $13M To Settle Drug Claims
- New Study Ties Biofilms To Jaw Deterioration
- Antitrust Lyme Disease Probe Sparks Debate
- Sanofi-Aventis Sues Over Eloxatin Ingredient
- Pfizer Settling Celebrex, Bextra Claims: Report
- Pharmacists' Right To Refuse Plan B Upheld
- Judge Denies Delaying Trial For Fen-Phen Lawyers
- Wider Fentora Use Could Encourage Abuse: FDA
- FDA Takes It On The Chin In Endotec Ruling
- Invitrogen Scientist Settles Insider Trading Case
- 3 Things Could Make Or Break An ANDA
- Dietary Products Tainted With Chromium: FDA
- Genetic Bias Bill Passes House With Ease
- The Best And Worst Patents For Generics To Fight
- Judges' Top Four Pet Peeves In Patent Litigation
- Zyprexa Securities Suit Dismissed As Time-Barred
- Sepracor, Breath Settle Xopenex Patent Fight
- In Cephalon Case, FTC Hopes For High Court Ruling
- FDA Scolds Merck About Conditions At Pa. Plant
- Health Insurers Accused Of Reimbursement Fraud